Furthermore, renin–angiotensin–aldosterone system (RAAS) modulators play a crucial role in improving sodium and potassium balance while reducing the risk of obesity-related hypertension and kidney dysfunction [120]. The gene discussed is REN; the disease is obesity due to melanocortin 4 receptor deficiency.